Dilaudid and Mucomyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilaudid (hydromorphone hydrochloride) and Mucomyst (acetylcysteine). Common drug interactions include hypoglycaemia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Dilaudid and Mucomyst. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

On Jul, 18, 2026

53 people who take Dilaudid and Mucomyst together, and have interactions are studied.

Dilaudid and Mucomyst drug interactions.

What are the common drug interactions of Dilaudid and Mucomyst, by gender? *:

female:

Hypoglycaemia (deficiency of glucose in the bloodstream)
Pyrexia (fever)
Abdominal pain
Acute hepatic failure
Bone pain
Brain injury
Colitis (inflammation of colon)
Coma (state of unconsciousness lasting more than six hours)
Decreased appetite
Dizziness

male:

Pneumonia
Febrile neutropenia (fever with reduced white blood cells)
Atrioventricular block complete (heart block complete)
Blood bicarbonate decreased
Blood creatinine increased
Blood magnesium decreased
Blood triglycerides increased
Bradycardia (abnormally slow heart action)
Cardiac arrest
Cardiogenic shock (inadequate circulation of blood)

What are the common drug interactions of Dilaudid and Mucomyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Hypertension (high blood pressure)
Infection
Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
Diarrhoea
Diarrhoea haemorrhagic (bloody diarrhoea)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Haematoma (collection of blood outside the blood vessels)
Pleural effusion (water on the lungs)
Pyrexia (fever)
Septic shock (shock due to blood infection)

10-19:

n/a

20-29:

Acute hepatic failure
Brain injury
Coma (state of unconsciousness lasting more than six hours)
Dizziness
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Loss of consciousness
Nausea (feeling of having an urge to vomit)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Loin pain (pain originates from kidney)

30-39:

Bradycardia (abnormally slow heart action)
Cardiac arrest
Cardiogenic shock (inadequate circulation of blood)
Electrocardiogram qt prolonged
Hepatic steatosis (fatty liver disease)
Hepatitis (inflammation of the liver)
Hepatocellular damage (liver damage)
Hepatomegaly (abnormal enlargement of the liver)
Hyperkalaemia (damage to or disease of the kidney)
Hyperlipidaemia (presence of excess lipids in the blood)

40-49:

Delirium (wild excitement)
Device related infection
Febrile neutropenia (fever with reduced white blood cells)
Hepatic failure (liver failure)
Hepatitis viral
Ischaemic hepatitis (decreased blood supply to the liver resulting in injury to liver cells)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Hypotension (abnormally low blood pressure)
Infection
Transaminases increased

50-59:

Cellulitis (infection under the skin)
Deformity (disfigurement)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Joint range of motion decreased (disease of joint movement)
Joint stiffness
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

60+:

Pneumonia
Febrile neutropenia (fever with reduced white blood cells)
Colitis (inflammation of colon)
Decreased appetite
Diarrhoea
Dysphagia (a condition in which swallowing is difficult or painful)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Enterocutaneous fistula
General physical health deterioration (weak health status)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 24 people, 45.28%
Depression: 13 people, 24.53%
High Blood Cholesterol: 13 people, 24.53%
Stress And Anxiety: 12 people, 22.64%
Itching: 12 people, 22.64%
Device Related Infection: 12 people, 22.64%
Nuclear Magnetic Resonance Imaging Brain: 12 people, 22.64%
Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 12 people, 22.64%
Herpes Zoster: 12 people, 22.64%
Constipation: 11 people, 20.75%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and Mucomyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously